NIC002 vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NIC002 vaccine, covering 2017-03-21 to 2017-03-21. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy, Safety, Tolerability and Immunogenicity of 100µg NIC002 Vaccine in Cigarette Smokers Who Are Motivated to Quit Smoking. [Phase 2]